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Original Article
Abdominal Tuberculosis in Adult: 10-Year Experience in 
a Teaching Hospital in Central Taiwan
Chia-Huei Chou, Mao-Wang Ho, Cheng-Mao Ho, Po-Chang Lin, Chin-Yun Weng,
Tsung-Chia Chen, Chih-Yu Chi*, Jen-Hsian Wang
Section of Infectious Diseases, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
BACKGROUND/PURPOSE: Tuberculosis (TB) is an important communicable disease worldwide. The 
clinical presentation of abdominal TB often mimics various gastrointestinal disorders and may delay 
accurate diagnosis. In this study, we conducted a 10-year retrospective study to investigate the clinical 
manifestations, treatment responses and outcomes of abdominal TB.
METHODS: This retrospective study recruited patients presenting between January 1998 and December 
2007; all patients ≥ 18 years of age with a diagnosis of abdominal TB were enrolled. Patient charts were 
thoroughly reviewed and clinical specimens were processed in the laboratory using the BBL MycoPrep 
System and BACTEC MGIT 960 Mycobacterial Detection System. Mycobacterium tuberculosis complex was 
confirmed by acid fast stain and the BD ProbeTec ET System. 
RESULTS: During the study period, 34 patients were diagnosed with abdominal TB. The mean age was 
55 ± 18 years. Fourteen patients (41%) had no risk factors; however, 20 patients (59%) had at least one risk 
factor. Abdominal pain (94.1%), abdominal fullness (91.2%), anorexia (88.2%) and ascites (76.5%) were the 
most common presenting symptoms. The peritoneum (88%) was the most commonly involved site. 
Patients with risk factors such as liver cirrhosis, end-stage renal disease and diabetes mellitus had a higher 
positive rate of acid-fast stain and mycobacterial culture from abdominal specimens (p = 0.02 and 0.05, 
respectively). The crude mortality rate was 9% and the attributed mortality rate was 3%.
CONCLUSION: In an endemic area like Taiwan, regardless of whether a patient has risk factors for 
TB, abdominal TB should be seriously considered as a differential diagnosis when a patient presents with 
gastrointestinal symptoms and unexplained ascites. 
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Introduction
Tuberculosis (TB) is an important communicable disease 
worldwide. According to a global report published in 2009 
by the World Health Organization, nearly one-third of the 
population of the world is infected with TB and 9.27 mil-
lion new cases of TB were diagnosed in 2007 (139 per 
100,000 population).1 Based on data from the Centers for 
Disease Control (CDC) of Taiwan, about 15,000 patients 
with TB are diagnosed annually, and one-fifth of them are 
396
C.H. Chou, et al
from central Taiwan.2 Any organ system may be affected 
by this pathogen, but pulmonary TB (80%) is the most 
common clinical manifestation.3 Prior to the development 
of anti-TB drugs, 50–90% of the patients with p ulmonary 
TB also had gastrointestinal (GI) tract involvement. With 
the introduction of effective anti-TB drugs, the incidence 
of GI tract TB decreased to 25% and is even rarer at this 
time.4–6 At present, approximately 350–400 new cases of 
TB are diagnosed at our institution annually and one-
third of them belong to the category of extra-pulmonary 
TB (3% with intra-abdominal involvement). Various intra-
abdominal organs could be affected by TB, such as the in-
testines, peritoneum, solid organs and mesenteric lymph 
nodes. Three different imaging findings of peritoneal TB 
have been described in the literature: a wet type with as-
cites, an encysted (loculated) type with localized abdomi-
nal swelling and a fibrotic type with abdominal masses.7 
The postulated mechanisms of acquiring GI tract TB in-
clude hematogenous spread from a primary pulmonary 
lesion, ingestion of infected sputum or spread from con-
tiguous tissues infected by Mycobacterium tuberculosis.7 The 
clinical manifestations of abdominal TB are protean and 
can mimic other disease processes, a phenomenon that may 
delay accurate diagnosis. Several articles on abdominal 
TB have been published in Taiwan (an endemic area for 
TB) over the past years,8–11 but the prevalence of abdomi-
nal TB, detailed descriptions of patient characteristics 
and differences in diagnostic yield rates among various 
methodologies in different populations are seldom men-
tioned. Therefore, we conducted this 10-year retrospective 
study to answer these clinically relevant questions.
Methods
Patient
Patient information was obtained from China Medical 
University Hospital (a 2,000-bed tertiary teaching hospi-
tal in central Taiwan). Between January 1998 and December 
2007, the medical records of all patients  ≥ 18 years of age 
diagnosed with abdominal TB, including GI tract, perito-
neum, mesenteric lymph nodes, or other intra-abdominal 
solid organs, were reviewed. The demographic data, un-
derlying diseases, clinical manifestations, laboratory data, 
diagnostic methods and outcomes were recorded. The 
susceptibility of the clinical isolates was also reviewed. 
A diagnosis of abdominal TB was made in patients with 
compatible symptoms, such as abdominal pain, fullness 
or distention, and if one of the following criteria was met: 
(1) positive culture of M. tuberculosis from ascites or biopsy 
specimens; or (2) demonstration of caseating granuloma 
on histological assessment of biopsy specimens and 
response well to anti-TB agents.
Laboratory methods
Specimens obtained from patients for Mycobacterium 
culture were initially decontaminated using the BBL 
MycoPrep System (Becton Dickinson Diagnostic Systems, 
Sparks, MD, USA). The processed material was incubated 
in BACTEC MGIT 960 Mycobacterial Detection System 
(Becton Dickinson Microbiology Systems, Sparks, MD, 
USA) and BBL Lowenstein-Jensen Medium (BBL/Becton 
Dickinson Microbiology Systems, Sparks, MD, USA). The 
isolated Mycobacterium species was further confirmed as 
M. tuberculosis complex using the BD ProbeTec ET System 
(Becton Dickinson Diagnostic, Sparks, MD, USA). 
Statistical analysis
The results were expressed as mean ± standard deviation, 
ranges, median or percentages. For continuous variables, 
the Mann-Whitney U test was used. Categorical data were 
analyzed using the χ2 test where appropriate. A two-tailed 
p value < 0.05 was considered statistically significant. All 
statistical calculations were done using the Statistical 
Package for the Social Sciences version 12.0 (SPSS Inc., 
Chicago, IL, USA). 
Results
During the study period, 34 patients were diagnosed with 
abdominal TB. The demographic characteristics of these 
patients are summarized in Table 1. There were 19 male 
patients and 15 female patients with a mean age of 55 ± 18 
years (range, 20–82 years). Twenty (58.8%) patients had risk 
factors such as liver cirrhosis (32.4%) and end-stage renal 
disease (ESRD), and were undergoing continuous ambulatory 
peritoneal dialysis (CAPD) (14.7%), and diabetes mellitus 
(DM) (8.8%). No risk factor could be identified in 14 (41.2%) 
patients (average age = 48 years) who were predominantly 
younger than those patients with risk factors (average 
age = 60 years). The median elapsed time between onset of 
 397
Abdominal tuberculosis in adult
symptoms to diagnosis of abdominal TB was 58 days 
(range, 10–175 days). In patients without risk factors, 
the duration of symptoms before TB diagnosis was simi-
lar (p = 0.90) to those with risk factors [59 days (range, 
10–172 days) vs. 58 days (range, 13–175 days), respectively]. 
Otherwise, there was no significant difference in the dura-
tion of hospitalization between patients with risk factors 
compared with those without (18 days vs. 15 days; p = 0.55).
Table 2 summarizes the clinical manifestations of the 
affected patients. Abdominal pain (94.1%) was the most com-
mon clinical presentation, followed by abdominal fullness 
(91.2%), anorexia (88.2%), ascites (76.5%) and fever (52.9%). 
Of these enrolled patients, 14 (41.2%) were initially diagnosed 
with peritoneal carcinomatosis of unknown origin. Another 
11 patients were regarded as having spontaneous bacterial 
peritonitis despite monocyte-predominant ascites data. 
Clinical specimens from 30 patients (26 ascites and 
4 tissues) were available for further evaluation with acid-
fast stain (AFS) and mycobacterial culture. Eighteen pa-
tients were smear-positive/culture-positive and two were 
smear-negative/culture-positive. Patients with risk factors 
had a significantly higher positive rate of AFS (p = 0.02) 
and mycobacterial culture (p = 0.05). 
Pathological examination was performed in 20 patients 
and all had characteristic pathological changes consistent 
with TB, including positive AFS (n = 10), Langhans giant 
cells (n = 16), caseous necrosis (n = 15) or granulomatous 
inflammation (n = 19). 
Numerous intra-abdominal sites may be infected by 
TB (Table 3). Of the 34 patients with evidence of intra-
abdominal involvement, the peritoneum was the most fre-
quently involved site (30 patients, 88.2%). In seven of these 
patients, the intra-abdominal organs were also involved 
(1 duodenum, 2 ileocecum, 1 large bowel, 2 ovary and 
1 mesenteric lymph nodes). There was no evidence of peri-
toneal involvement in four patients; two had hepatic TB 
diagnosed by liver biopsy, one had anal ulceration and the 
remaining one had ileocecal involvement. All patients re-
ceived plain film chest radiographs (CXR), and 17 patients 
had abnormal radiographic findings including cavitary 
lesions, alveolar processes and pleural effusion. Pulmonary 
TB was confirmed in 8/17 patients by positive sputum 
AFS and mycobacterial culture. Table 4 shows the ascites 
profile data from 26 patients: 14 with risk factors and 12 
without. Higher diagnostic yields of AFS and mycobacte-
rial culture were found in patients with risk factors, and 
Table 1. Demographic characteristics and risk factors of 
34 patients with abdominal tuberculosisa
Characteristic 
Age
 Mean ± SD 55 ± 18
 Median (range) 58 (20–82)
Sex
 Male:female 19:15
Risk factor
 Liver cirrhosis 11 (32.4)
 ESRD on CAPD 5 (14.7)
 Diabetes mellitus 3 (8.8)
 Malignancy 4 (11.8)
 Previous gastrectomy 3 (8.8)
 Prolonged steroid (> 7 d)  1 (2.9)
 No major systemic disorders 14 (41.2)
Duration of diagnosis (d)
 Mean 63
 Median (range) 58 (10–175)
aData presented as mean ± standard deviation, median (range) or 
n (%). SD = Standard deviation. ESRD = end-stage renal disease; CAPD = 
continuous ambulatory peritoneal dialysis.
Table 2. Clinical features in 34 patients with abdominal 
tuberculosis
Symptoms n (%)
Abdominal pain 32 (94.1)
Abdominal fullness 31 (91.2)
Anorexia 30 (88.2)
Ascites 26 (76.5)
Fever 18 (52.9)
Night sweating 14 (41.2)
Nausea/vomiting 12 (35.3)
Tenesmus 10 (29.4)
Body weight loss 10 (29.4)
Cough 9 (26.5)
Constipation 8 (23.5)
Diarrhea 6 (17.6)
Ileus 5 (14.7)
Bloody stool 4 (11.8)
Bowel perforation 1 (2.9)
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these findings were statistically significant (AFS, p = 0.05; 
TB culture, p = 0.01).
Twenty TB isolates from abdominal specimens were 
submitted for susceptibility testing and all were suscepti-
ble to currently used first-line anti-TB drugs. Treatment 
strategies were based on the guidelines proposed by the 
CDC of Taiwan and the therapeutic regimen consisted of 
isoniazid, rifampicin, ethambutol, streptomycin and pyrazi-
namide in various combinations for 6–12 months.12 
Thirty patients completed the course of anti-TB therapy. 
The mean duration of treatment was 225 ± 56 days (range, 
180–360 days). Of the patients (n = 30) that completed the 
treatment, 15 were regularly followed up at our outpa-
tient clinic. The median duration of follow-up was 303 
days (range, 34–956 days). No relapse was detected during 
the follow-up period. During treatment, seven patients ex-
perienced adverse drug effects such as hepatitis, gastroin-
testinal upset, skin rashes and peripheral neuropathy. Of 
those patients who did not complete the treatment course, 
three died during therapy and one was lost to follow-up. 
Only one death was attributable to abdominal TB. This 
patient suffered from ileocecal TB enteritis complicated 
by intestinal perforation and septic shock. The crude 
mortality rate was 9% and the attributed mortality was 3%. 
Discussion
In this study, male and female patients were nearly equally 
affected by abdominal TB (male to female ratio = 1.26), 
a result similar to that reported by the CDC of Taiwan 
(male to female ratio = 2) and Chen et al (male to female 
ratio = 1.62).11 However, this finding was different from 
other earlier studies in Taiwan.8,9 In those studies, male 
patients comprised a significant proportion of the affected 
population (ratio = 2.5:1 to 4.9:1). Possible explanations 
for these discordant results may be the changing gender 
composition of the general population in Taiwan since 
early 1990 s13 or sampling bias in those studies.8,9
Table 3. Anatomical location of lesion in 34 patients with abdominal tuberculosisa,b
Site With risk factors (n = 20) Without risk factors (n = 14)
Peritoneal involvement 18 (90.0) 12 (85.7)
 With other intra-abdominal organ 1 (5.0) 6 (42.9)
  Duodenum 0 (0) 1 (7.1)
  Ileocecum 1 (5.0) 1 (7.1)
  Large bowel 0 (0) 1 (7.1)
  Ovary 0 (0) 2 (14.3)
  Mesenteric lymph nodes 0 (0) 1 (7.1)
Non-peritoneal involvement 2 (10.0) 2 (14.3)
 Liver 0 (0) 2 (14.3)
 Anus 1 (5.0) 0 (0)
 Ileocecum 1 (5.0) 0 (0)
aData presented as n (%); brisk factors included liver cirrhosis, end-stage renal disease, diabetes mellitus, malignancy, gastrectomy and pro-
longed steroid use (> 7 days). 
Table 4. Ascites analysis in 26 patients with abdominal tuberculosis and present with ascitesa,b
Ascites analysis With risk factors (n = 14) Without risk factors (n = 12) p
Neutrophil predominant 7 (50.0) 2 (16.7) 0.11
Monocyte predominant 7 (50.0) 10 (83.3) 0.11
Positive AFS 11 (78.6) 4 (33.3) 0.05
Positive TB culture 12 (85.7) 4 (33.3) 0.01
aData presented as n (%); brisk factors included liver cirrhosis, end-stage renal disease, diabetes mellitus, malignancy, gastrectomy and 
prolonged steroid use (> 7days). AFS = Acid-fast stain; TB = tuberculosis.
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Abdominal TB can affect any age group. In a study 
conducted by Sharma et al,7 most affected patients were 
between 21–45 years of age. This result was clearly differ-
ent from that of the current study. The mean age of the 
patients in our study was 58 ± 18 years (range, 20–82 
years) and this is similar to other reports from Taiwan.8,11 
Liver cirrhosis, especially caused by alcoholism, is a known 
risk factor for TB peritonitis.11,14 In our study, 32.4% of 
the patients suffered from liver cirrhosis and this was also 
the leading risk factor for abdominal TB. Other risk fac-
tors, such as ESRD with CAPD, malignancy and DM, were 
also recorded. Interestingly, 14 patients (41.2%) had no 
identifiable risk factors. This observation has never been 
described in other studies. The reason that these patients 
acquired abdominal TB needs further investigation. 
The clinical manifestations of abdominal TB are quite 
protean. Similar to previous reports,7,15 abdominal pain 
(94.1%) was the most common clinical presentation in this 
study, followed by abdominal fullness (91.2%) and ano-
rexia (88.2%). According to a study performed in India,7 
fever was recorded in half of the patients. In our study, the 
majority of the symptoms (Table 2) were confined to the 
GI tract, with the exception of cough, which was observed 
in 26.5% patients with abdominal TB. The proportion of 
patients with a cough reported by other studies ranges from 
4% to 27%.8–10,16,17 No specific physical signs could be as-
cribed to abdominal TB; the classical “doughy” abdomen 
is seldom reported in clinical practice.18 None of our 
patients had this characteristic sign. 
Routine laboratory tests have limited value in the diag-
nosis of abdominal TB.8,9,11,19 Among the study cases, 17 
patients (50.0%) had abnormal findings on CXR and eight 
of them had a positive sputum culture for TB. Compared 
with patients with co-morbidities, those without risk fac-
tors had a higher proportion of abnormal CXR (p = 0.001), 
but statistically insignificant differences in the positive 
rate of sputum and AFS and TB culture (p = 0.42). However, 
a higher proportion of positive AFS and TB culture re-
sults from specimens other than sputum were noted in 
the patients with risk factors (AFS, p = 0.02; TB culture, 
p = 0.05). Impaired cellular immunity in patients with liver 
cirrhosis, ESRD and DM has been documented by investi-
gators,20–22 and the main immunological response to TB 
is through innate cellular immunity.23 Impaired immu-
nological responses in patients with co-morbid diseases 
might facilitate the replication of this pathogenic myco-
bacterium and this phenomenon could result in higher 
positive culture rate and AFS rates in this population. As 
seen in prior studies,24–27 lymphocytes were the predomi-
nant cell-type in the ascites of patients with TB peritoni-
tis; however, in cases receiving CAPD, the predominant 
cells were neutrophils (80% of patients). This observation 
had also been described in previous studies.28–30
With adequate and appropriate treatment, most pa-
tients with abdominal TB show good responses and have 
a good prognosis.4,8–11 In our study population, a good 
prognosis was observed in patients that completed the 
whole treatment course. Twenty percent of patients expe-
rienced adverse drug effects. In contrast to other local 
studies previously done in Taiwan, the mortality rate (9%) 
determined in our study was lower than that from studies 
conducted in Taipei in the 1990 s (14.8% and 13.2%)8,9 and 
in southeastern Taiwan (20.8%).11 Possible explanations for 
the lower mortality rate in this study are inadequate drug 
therapy during the 1990 s, different underlying conditions, 
different patient populations and limited access to the 
healthcare system (particularly in southeastern Taiwan). 
This retrospective study has some unavoidable limita-
tions, such as incomplete examination in all patients and 
patient recall bias; however, there are still several impor-
tant points that should be kept in mind during daily clini-
cal practice. In terms of protean clinical manifestations of 
abdominal TB and the ease of delayed diagnosis, a high 
index of suspicion is always required. In an endemic area 
like Taiwan, regardless of whether patients have risk fac-
tors for TB, abdominal TB should be actively considered 
as a differential diagnosis in patients with gastrointesti-
nal symptoms and unexplained ascites. 
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